Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate.
暂无分享,去创建一个
[1] O. Rotstein. Role of fibrin deposition in the pathogenesis of intraabdominal infection , 1992, European Journal of Clinical Microbiology and Infectious Diseases.
[2] J. Yee,et al. Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] S. Silverman,et al. Intracavitary urokinase for enhancement of percutaneous abscess drainage: phase II trial. , 2000, AJR. American journal of roentgenology.
[4] I. Kelly,et al. Adjuvant urokinase therapy in percutaneous drainage of a multiloculated splenic abscess. , 1999, Journal of vascular and interventional radiology : JVIR.
[5] B. A. Mueller,et al. Intraperitoneal Thrombolytic Therapy for Peritoneal Dialysis–Associated Peritonitis , 1998, The Annals of pharmacotherapy.
[6] Y. Sivan,et al. Treatment of loculated pleural effusion with intrapleural urokinase in children. , 1997, Journal of pediatric surgery.
[7] H. van Goor,et al. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator. , 1995, Journal of the American College of Surgeons.
[8] J. van der Meer,et al. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. , 1994, Journal of the American College of Surgeons.
[9] J. Haaga,et al. Fluid flow during percutaneous drainage procedures: an in vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase. , 1993, AJR. American journal of roentgenology.
[10] J. Haaga,et al. Safety of intracavitary urokinase with percutaneous abscess drainage. , 1993, AJR. American journal of roentgenology.
[11] R. W. Holden,et al. Plasminogen activators: pharmacology and therapy. , 1990, Radiology.
[12] D. McRitchie,et al. Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing. , 1990, Annals of surgery.
[13] D. McRitchie,et al. Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation. , 1989, Archives of surgery.
[14] O. Rotstein,et al. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. , 1988, The Journal of infectious diseases.
[15] Simmons Rl,et al. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. , 1980 .